How severe is CVE-2022-2054?

CVE-2022-2054 has a CVSS 3.x base score of 8.4, rated high severity. It is exploitable over local access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2022-2054 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (41st percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-2054?

CVE-2022-2054 affects Nuitka. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2022-2054?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2022-2054 published?

CVE-2022-2054 was published on 2022-06-12 and last updated on 2026-06-17.

CVE-2022-2054

CVE-2022-2054 is a high-severity vulnerability in Nuitka with a CVSS 3.x base score of 8.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-94.

Key facts

Severity: High (CVSS 3.x base score 8.4)
CVSS v2: 7.2
EPSS exploit prediction: 1% (41st percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-94
Affected product: Nuitka
Published: 2022-06-12
Last modified: 2026-06-17

Description

Code Injection in GitHub repository nuitka/nuitka prior to 0.9.

Frequently asked questions

What is CVE-2022-2054?: Code Injection in GitHub repository nuitka/nuitka prior to 0.9.
How severe is CVE-2022-2054?: CVE-2022-2054 has a CVSS 3.x base score of 8.4, rated high severity. It is exploitable over local access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-2054 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (41st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-2054?: CVE-2022-2054 affects Nuitka. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-2054?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2022-2054 published?: CVE-2022-2054 was published on 2022-06-12 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:nuitka:nuitka:*:*:*:*:*:*:*:*

Other CWE-94 (Code Injection) vulnerabilities

CVE-2026-57624 — Critical (CVSS 10.0): Unauthenticated Remote Code Execution (RCE) in Blocksy Companion Pro <= 2.1.46 versions.
CVE-2026-10134 — Critical (CVSS 10.0): IBM Langflow OSS 1.0.0 through 1.9.3 allows an attacker to read every secret available to the Langflow process, read…
CVE-2026-53576 — Critical (CVSS 10.0): Kestra is an open-source, event-driven orchestration platform. Prior to 1.0.45 and 1.3.21, the authentication filter…
CVE-2026-10561 — Critical (CVSS 10.0): IBM Langflow OSS 1.0.0 through 1.9.3 has an vulnerability due to an improper isolation of Python execution combined…
CVE-2026-25470 — Critical (CVSS 10.0): Improper Control of Generation of Code ('Code Injection') vulnerability in ACPT ACPT (Pro) - Custom Post Types Plugin…
CVE-2026-48836 — Critical (CVSS 10.0): Unauthenticated Remote Code Execution (RCE) in Easy Invoice <= 2.1.19 versions.

Browse all CWE-94 (Code Injection) vulnerabilities →